CASI PHARMACEUTICALS, INC. (CASIF) Gross margin 2020–2025
CASI PHARMACEUTICALS, INC. (CASIF) gross margin by fiscal year — reported gross profit divided by reported revenue.
48.6%FY2025 · since FY2020: 37.6% → 48.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 48.6% | +9.6 pp |
| FY2024 | 39.1% | -20.1 pp |
| FY2023 | 59.2% | -12.5 pp |
| FY2022 | 71.7% | +13.0 pp |
| FY2021 | 58.7% | +21.1 pp |
| FY2020 | 37.6% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice